Sarcoma
Volume 2008 (2008), Article ID 459386, 6 pages
doi:10.1155/2008/459386
Clinical Study

Frequency of Certain Established Risk Factors in Soft Tissue Sarcomas in Adults: A Prospective Descriptive Study of 658 Cases

Nicolas Penel,1 Jessica Grosjean,1 Yves Marie Robin,2 Luc Vanseymortier,1,3 Stéphanie Clisant,4 and Antoine Adenis3

1Département de Cancérologie Générale, Centre Oscar Lambret, 59020 Lille, France
2Laboratoire d'Anatomopathologie, Centre Oscar Lambret, 59020 Lille, France
3Département de Cancérologie Digestive et Urologique, Centre Oscar Lambret, 59020 Lille, France
4Unité de Recherche Clinique, Centre Oscar Lambret, 59020 Lille, France

Received 19 June 2007; Revised 20 January 2008; Accepted 6 March 2008

Academic Editor: Ole Nielsen

Copyright © 2008 Nicolas Penel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. H. Zahm and J. F. Fraumeni, Jr., “The epidemiology of soft tissue sarcoma,” Seminars in Oncology, vol. 24, no. 5, 504 pages, 1997.
  2. F. Levi, C. La Vecchia, L. Randimbison, and V.-C. Te, “Descriptive epidemiology of soft tissue sarcomas in Vaud, Switzerland,” European Journal of Cancer, vol. 35, no. 12, 1711 pages, 1999. View at Publisher · View at Google Scholar
  3. J.-M. Coindre, P. Terrier, L. Guillou, et al., “Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group,” Cancer, vol. 91, no. 10, 1914 pages, 2001. View at Publisher · View at Google Scholar
  4. B. Samuelsson and S. Samuelsson, “Neurofibromatosis in Gothenburg, Sweden. I. Background, study design and epidemiology,” Neurofibromatosis, vol. 2, no. 1, 6 pages, 1989.
  5. T. Frebourg, A. Abel, C. Bonaiti-Pellie, et al., “Le syndrome de Li-Fraumeni: mise au point, données nouvelles et recommandations pour la prise en charge,” Bulletin du Cancer, vol. 88, no. 6, 581 pages, 2001.
  6. R. A. Kleinerman, M. A. Tucker, D. H. Abramson, J. M. Seddon, R. E. Tarone, and J. F. Fraumeni, Jr., “Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma,” Journal of the National Cancer Institute, vol. 99, no. 1, 24 pages, 2007. View at Publisher · View at Google Scholar · View at PubMed
  7. J. A. Greer, Jr., K. D. Devine, and D. C. Dahlin, “Gardner's syndrome and chondrosarcoma of the hyoid bone,” Archives of Otolaryngology, vol. 103, no. 7, 425 pages, 1977.
  8. M. Goto, R. W. Miller, Y. Ishikawa, and H. Sugano, “Excess of rare cancers in Werner syndrome (adult progeria),” Cancer Epidemiol Biomarker & Prevention, vol. 5, no. 4, 239 pages, 1996.
  9. L. Lo Muzio, P. Nocini, P. Bucci, G. Pannone, U. Consolo, and M. Procaccini, “Early diagnosis of nevoid basal cell carcinoma syndrome,” Journal of the American Dental Association, vol. 130, no. 5, 669 pages, 1999.
  10. M. Arlen, N. L. Higinbotham, A. G. Huvos, R. C. Marcove, T. Miller, and I. C. Shah, “Radiation-induced sarcoma of bone,” Cancer, vol. 28, no. 5, 1087 pages, 1971. View at Publisher · View at Google Scholar
  11. W. Lawrence, Jr., W. L. Donegan, N. Natarajan, C. Mettlin, R. Beart, and D. Winchester, “Adult soft tissue sarcomas: a pattern of care survey of the American College of Surgeons,” Annals of Surgery, vol. 205, no. 4, 349 pages, 1987. View at Publisher · View at Google Scholar
  12. M. F. Brennan, “The surgeon as a leader in cancer care: lessons learned from the study of soft tissue sarcoma,” Journal of the American College of Surgeons, vol. 182, no. 6, 520 pages, 1996.
  13. P. Karlsson, E. Holmberg, K.-A. Johansson, L.-G. Kindblom, J. Carstensen, and A. Wallgren, “Soft tissue sarcoma after treatment for breast cancer,” Radiotherapy and Oncology, vol. 38, no. 1, 25 pages, 1996. View at Publisher · View at Google Scholar
  14. G. K. Jacobsen, A. Mellemgaard, S. A. Engelholm, and H. Moller, “Increased incidence of sarcoma in patients treated for testicular seminoma,” European Journal of Cancer, vol. 29, no. 5, 664 pages, 1993. View at Publisher · View at Google Scholar
  15. F. E. van Leeuwen, W. J. Klokman, A. Hagenbeek, et al., “Second cancer risk following Hodgkin's disease: a 20-year follow-up study,” Journal of Clinical Oncology, vol. 12, no. 2, 312 pages, 1994.
  16. M. S. Brady, J. J. Gaynor, and M. F. Brennan, “Radiation-associated sarcoma of bone and soft tissue,” Archives of Surgery, vol. 127, no. 12, 1379 pages, 1992.
  17. S. W. Weiss and F. M. Enzinger, “Malignant fibrous histiocytoma. An analysis of 200 cases,” Cancer, vol. 41, no. 6, 2250 pages, 1978. View at Publisher · View at Google Scholar
  18. P. Roy, M. A. Clark, and J. M. Thomas, “Stewart-Treves syndrome—treatment and outcome in six patients from a single centre,” European Journal of Surgical Oncology, vol. 30, no. 9, 982 pages, 2004. View at Publisher · View at Google Scholar · View at PubMed
  19. Y. M. Kirova, L. Gambotti, Y. De Rycke, J. R. Vilcoq, B. Asselain, and A. Fourquet, “Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review,” International Journal of Radiation Oncology Biology Physics, vol. 68, no. 2, 359 pages, 2007. View at Publisher · View at Google Scholar · View at PubMed
  20. S. A. Sorensen, J. J. Mulvihill, and A. Nielsen, “Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms,” New England Journal of Medicine, vol. 314, no. 16, 1010 pages, 1986.
  21. E. B. Harvey and L. A. Brighton, “Second cancer following cancer of the breast in Connecticut, 1935–82,” Journal of the National Cancer Institute, vol. 68, 99 pages, 1985.
  22. J. G. Guccion and F. M. Enzinger, “Malignant schwannoma associated with von Recklinghausen's neurofibromatosis,” Virchows Archiv, vol. 383, no. 1, 43 pages, 1979. View at Publisher · View at Google Scholar
  23. R. H. Hruban, M. H. Shiu, R. T. Senie, and J. M. Woodruff, “Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases,” Cancer, vol. 66, no. 6, 1253 pages, 1990. View at Publisher · View at Google Scholar
  24. D. Kotiligam, A. J. Lazar, R. E. Pollock, and D. Lev, “Desmoid tumor: a disease opportune for molecular insights,” Histology and Histopathology, vol. 23, no. 1, 117 pages, 2008.
  25. M. Gega, H. Yanagi, R. Yoshikawa, et al., “Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis,” Journal of Clinical Oncology, vol. 24, no. 1, 102 pages, 2006. View at Publisher · View at Google Scholar · View at PubMed
  26. J. A. Bridge and A. A. Sandberg, “Cytogenetic and molecular genetic techniques as adjunctive approaches in the diagnosis of bone and soft tissue tumors,” Skeletal Radiology, vol. 29, no. 5, 249 pages, 2000. View at Publisher · View at Google Scholar
  27. M. Kogevinas, T. Kauppinen, R. Winkelmann, et al., “Soft tissue sarcoma and non-Hodgkin's lymphoma in workers exposed to phenoxy herbicides, chlorophenols, and dioxins: two nested case-control studies,” Epidemiology, vol. 6, no. 4, 396 pages, 1995. View at Publisher · View at Google Scholar
  28. P. C. Valery, G. Williams, A. C. Sleigh, E. A. Holly, N. Kreiger, and C. Bain, “Parental occupation and Ewing's sarcoma: pooled and meta-analysis,” International Journal of Cancer, vol. 115, no. 5, 799 pages, 2005. View at Publisher · View at Google Scholar · View at PubMed
  29. B. D. Cheson, D. A. Vena, J. Barrett, and B. Freidlin, “Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias,” Journal of Clinical Oncology, vol. 17, no. 8, 2454 pages, 1999.